P value for chi-square test is 0.011. + For 10 patients who were confirmed to have N2 disease in EBUS-TBNA, the interval between PET-CT and EBUS-TBNA were used. # Analysis was done in 851 patients after excluding 10 patients who were confirmed to have N2 disease in EBUS-TBNA and did not undergo MLND.
NSCLC, non-small cell lung cancer; CT, computed tomography; OR, odds ratio; CI, confidence interval; PET-CT, integrated positron emission tomography and computed tomography; MLND, mediastinal lymph node dissection. P value for chi-square test is 0.149. + For 10 patients who were confirmed to have N2 disease in EBUS-TBNA, the interval between PET-CT and EBUS-TBNA were used. # Analysis was done in 475 patients after excluding 10 patients who were confirmed to have N2 disease in EBUS-TBNA and did not undergo MLND.
NSCLC, non-small cell lung cancer; CT, computed tomography; OR, odds ratio; CI, confidence interval; PET-CT, integrated positron emission tomography and computed tomography; MLND, mediastinal lymph node dissection. Model 2: Further adjusted for age (continuous), sex, smoking history (never or ever), and lobar location (right or left) of tumour.
NSCLC, non-small cell lung cancer; CT, computed tomography; OR, odds ratio; CI, confidence interval; MLND, mediastinal lymph node dissection.
